These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 332337

  • 1. Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells.
    Chou TC, Arlin Z, Clarkson BD, Phillips FS.
    Cancer Res; 1977 Oct; 37(10):3561-70. PubMed ID: 332337
    [No Abstract] [Full Text] [Related]

  • 2. Effects of tetrahydrouridine on the uptake and metabolism of 1-beta-D-arabinofuranosylcytosine in human normal and leukemic cells.
    Ho DH, Carter CJ, Brown NS, Hester J, McCredie K, Benjamin RS, Freireich EJ, Bodey GP.
    Cancer Res; 1980 Jul; 40(7):2444-6. PubMed ID: 6248205
    [No Abstract] [Full Text] [Related]

  • 3. Biochemical studies with 1 beta-D-arabinofuranosylcytosine in human leukemic leukocytes and normal bone marrow cells.
    Creasey WA, DeConti RC, Kaplan SR.
    Cancer Res; 1968 Jun; 28(6):1074-81. PubMed ID: 5241767
    [No Abstract] [Full Text] [Related]

  • 4. Separation of leukemic cells into proliferative and quiescent subpopulations by centrifugal elutriation.
    Preisler HD, Walczak I, Renick J, Rustum YM.
    Cancer Res; 1977 Nov; 37(11):3876-80. PubMed ID: 71201
    [Abstract] [Full Text] [Related]

  • 5. 1-beta-D-arabinofuranosylcytosine (ara-C) deamination in human leukemic myeloblasts is not a mechanism of resistance to ara-C therapy.
    Harris AL.
    Cancer Res; 1981 Jul; 41(7):2977-9. PubMed ID: 6941850
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and cellular determinants of response to 1-beta-arabinofuranosylcytosine (ara-C).
    Riva CM, Rustum YM, Preisler HD.
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):1-8. PubMed ID: 3859925
    [No Abstract] [Full Text] [Related]

  • 7. Correlation between leukemic cell retention of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and response to therapy.
    Rustum YM, Preisler HD.
    Cancer Res; 1979 Jan; 39(1):42-9. PubMed ID: 282940
    [No Abstract] [Full Text] [Related]

  • 8. Effects of the antineoplastic alkaloid acronycine on nucleoside uptake and incorporation into nucleic acids by cultured L5178Y cells.
    Dunn BP, Gout PW, Beer CT.
    Cancer Res; 1973 Oct; 33(10):2310-9. PubMed ID: 4517733
    [No Abstract] [Full Text] [Related]

  • 9. Cellular pharmacology of 1-beta-D-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cells.
    Momparler RL, Onetto-Pothier N, Bouffard DY, Momparler LF.
    Cancer Chemother Pharmacol; 1990 Oct; 27(2):141-6. PubMed ID: 2249330
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.
    Grant S, Lehman C, Cadman E.
    Cancer Res; 1980 May; 40(5):1525-31. PubMed ID: 7370990
    [No Abstract] [Full Text] [Related]

  • 11. [Metabolism of bone marrow leukocyte elements in chronic myeloid leukemia].
    Lapotnikov VA, Lebedeva NP, Moskalik IG, Onushchenko IA, Filev LV.
    Probl Gematol Pereliv Krovi; 1972 Feb; 17(2):3-6. PubMed ID: 4505857
    [No Abstract] [Full Text] [Related]

  • 12. The generation time of human leukemic myeloblasts.
    Greenberg ML, Chanana AD, Cronkite EP, Giacomelli G, Schiffer LM, Stryctmans PA, Vincent PC.
    Lab Invest; 1972 Mar; 26(3):245-52. PubMed ID: 4502025
    [No Abstract] [Full Text] [Related]

  • 13. Timed sequential therapy of human leukemia based upon the response of leukemic cells to humoral growth factors.
    Burke PJ, Karp JE, Braine HG, Vaughan WP.
    Cancer Res; 1977 Jul; 37(7 Pt 1):2138-46. PubMed ID: 266416
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W, Hug V, Keating MJ, Chubb S.
    Cancer Res; 1980 Mar; 40(3):588-91. PubMed ID: 6937239
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characteristics of cell proliferation in acute leukemia.
    Cheung WH, Rai KR, Sawitsky A.
    Cancer Res; 1972 May; 32(5):939-42. PubMed ID: 4502172
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.